Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/111640
Title: Modeling the Antitubulin Activity of Benzimidazol-2-yl Carbamates: Mini-review
Authors: Obydennov, K. L.
Kanwugu, O. N.
Kalinina, T. A.
Glukhareva, T. V.
Issue Date: 2021
Publisher: American Institute of Physics Inc.
AIP Publishing
Citation: Modeling the Antitubulin Activity of Benzimidazol-2-yl Carbamates: Mini-review / K. L. Obydennov, O. N. Kanwugu, T. A. Kalinina et al. // AIP Conference Proceedings. — 2021. — Vol. 2388. — 030031.
Abstract: The biological activity of 5-benzimidazol-2-yl carbamate derivatives is associated with their ability to form a complex with /3-tubulin and, consequently, disrupt the process of assembly of microtubules of the cytoskeleton of cells. Over the past 10 years, the understanding of the binding of 5-benzimidazol-2-yl carbamate derivatives to the /3-tubulin subunit has increased significantly, mainly due to the published crystal structures of their ligand-receptor complexes. However, some details of this process could be predicted based on the results of molecular modeling before the publication of the corresponding crystal data. This mini-review summarizes the results of such works. © 2021 Author(s).
URI: http://elar.urfu.ru/handle/10995/111640
Access: info:eu-repo/semantics/openAccess
Conference name: 4th International Conference on Modern Synthetic Methodologies for Creating Drugs and Functional Materials, MOSM 2020
Conference date: 16 November 2020 through 20 November 2020
SCOPUS ID: 85120434093
PURE ID: 29071275
ISSN: 0094-243X
ISBN: 9780735441422
DOI: 10.1063/5.0068469
Sponsorship: This research was supported by the Russian Foundation for Basic Research (grant No. 18-316-20018).
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85120434093.pdf738,67 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.